AU7681091A - Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases - Google Patents

Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases

Info

Publication number
AU7681091A
AU7681091A AU76810/91A AU7681091A AU7681091A AU 7681091 A AU7681091 A AU 7681091A AU 76810/91 A AU76810/91 A AU 76810/91A AU 7681091 A AU7681091 A AU 7681091A AU 7681091 A AU7681091 A AU 7681091A
Authority
AU
Australia
Prior art keywords
medication
medicament
prevention
pulmonary diseases
human leucocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76810/91A
Inventor
John R Hoidal
Thomas P. Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU7681091A publication Critical patent/AU7681091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
AU76810/91A 1990-04-05 1991-04-02 Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases Abandoned AU7681091A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50556290A 1990-04-05 1990-04-05
US505562 1990-04-05

Publications (1)

Publication Number Publication Date
AU7681091A true AU7681091A (en) 1991-10-30

Family

ID=24010817

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76810/91A Abandoned AU7681091A (en) 1990-04-05 1991-04-02 Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases

Country Status (2)

Country Link
AU (1) AU7681091A (en)
WO (1) WO1991015216A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
US6063773A (en) * 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
US6339075B1 (en) 1997-06-30 2002-01-15 The University Of British Columbia Use of dextran and other polysaccharides to improve mucus clearance
CA2209342A1 (en) * 1997-06-30 1998-12-30 The University Of British Columbia Use of dextran and other oligomeric saccharides to improve airway clearance
EP1212047A2 (en) * 1999-08-26 2002-06-12 The Governors Of The University Of Alberta Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto
WO2005070970A1 (en) * 2004-01-16 2005-08-04 Fibrogen, Inc. Connective tissue growth factor signaling
SE0401069D0 (en) 2004-04-26 2004-04-26 Anamar Medical Ab Use of Compounds for the Treatment of Diseases and Conditions
ES2583527T3 (en) * 2007-05-31 2016-09-21 Paradigm Biopharmaceuticals Limited Sulfated xylanes for the treatment or prophylaxis of respiratory diseases
PT2846809T (en) 2012-05-09 2021-02-05 Cantex Pharmaceuticals Inc Treatment of myelosuppression
US10052346B2 (en) 2015-02-17 2018-08-21 Cantex Pharmaceuticals, Inc. Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU731967A1 (en) * 1977-12-19 1980-05-05 Киевский Ордена Трудового Красного Знамени Научно-Исследовательский Институт Туберкулеза И Грудной Хирургии Им. Академика Ф.Г.Яновского Method of treating inflammatory pulmonary dieases
FR2478646A2 (en) * 1980-03-20 1981-09-25 Choay Sa MUCOPOLYSACCHARIDIC COMPOSITION HAVING A COAGULATION REGULATING ACTIVITY, MEDICAMENT CONTAINING THE SAME, AND METHOD FOR OBTAINING THE SAME
US4725545A (en) * 1983-05-09 1988-02-16 Georgia Tech Research Corporation Aryl sulfonyl fluoride inhibitors of elastase and chymotrypsin-like enzymes
US4847202A (en) * 1983-05-09 1989-07-11 Georgia Tech Research Institute Heterocyclic inhibitors of serine proteases
DE3323389A1 (en) * 1983-06-29 1985-01-10 B. Braun Melsungen Ag, 3508 Melsungen MEDICINAL PRODUCTS ON THE MOUTH OF THE MOUTH, THE NOSE AND / OR THE VENICE ON THE BASIS OF HEPARIN AND TENSIDES
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4808570A (en) * 1984-02-24 1989-02-28 University Of California Compositions and method for improving wound healing
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses

Also Published As

Publication number Publication date
WO1991015216A1 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
AU8933391A (en) Medical drug formulation and delivery system
AU6042696A (en) Drug delivery catheters and methods of use
FI941979A (en) Pharmaceutical products for the treatment of tumor diseases and a method for their preparation
AU2326892A (en) Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use
KR100206481B1 (en) Galenic form for ocular administration and process for the preparation of same
DE69326539D1 (en) CYTOTOXIC MEDICINE THERAPY
AU4048295A (en) Peptide medicaments for the treatment of disease
IL130784A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
AU4028895A (en) Vaccine and treatment method of Human Immunodeficiency Virus
AU7681091A (en) Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
HK1009101A1 (en) Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients
AU4759390A (en) Method of medical treatment of alzheimer's disease
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
AU3562195A (en) Preparations containing aspb28 human insulin and nicotinamide
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
EP0511499A3 (en) Method and catheter for controlled intravascular drug delivery
EP0744176A3 (en) Methods for inhibiting bone loss
AU8015398A (en) Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
HUT68007A (en) Pharmaceutical compositions for preventing and treating retinal diseases and process for preparing them
HUP9800829A3 (en) Collagen-based methods and formulations for the treatment of immune system-mediated diseases
AU4058789A (en) Medicinal drug, method of treatment of human diseases therewith, and method and device for producing and preserving thereof
AU5201793A (en) Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis